dc.creator | Bottecchia, Marcelle | |
dc.creator | Souto, Francisco J. D. | |
dc.creator | O, Kycia M. R. | |
dc.creator | Amendola, Marcia | |
dc.creator | Brandão, Carlos E. | |
dc.creator | Niel, Christian | |
dc.creator | Gomes, Selma A. | |
dc.date | 2018-08-02T14:57:58Z | |
dc.date | 2018-08-02T14:57:58Z | |
dc.date | 2008 | |
dc.date.accessioned | 2023-09-26T20:07:30Z | |
dc.date.available | 2023-09-26T20:07:30Z | |
dc.identifier | BOTTECCHIA, Marcelle; et al. Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy: characterization of genotype G in Brazil. BMC Microbiology, v. 8, n.11, 10p, Jan. 2008. | |
dc.identifier | 1471-2180 | |
dc.identifier | https://www.arca.fiocruz.br/handle/icict/27796 | |
dc.identifier | 10.1186/1471-2180-8-11 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/8849086 | |
dc.description | Lamivudine is an oral nucleoside analogue widely used for the treatment of chronic hepatitis B. The main limitation of lamivudine use is the selection of resistant mutations that increases with time of utilization. Hepatitis B virus (HBV) isolates have been classified into eight genotypes (A to H) with distinct geographical distributions. HBV genotypes may also influence pathogenic properties and therapeutic features. Here, we analyzed the HBV genotype distribution and the nature and frequency of lamivudine resistant mutations among 36 patients submitted to lamivudine treatment for 12 to 84 months. | |
dc.format | application/pdf | |
dc.language | eng | |
dc.publisher | BioMed Central | |
dc.rights | open access | |
dc.subject | Genótipos do vírus da Hepatite B | |
dc.subject | Mutações | |
dc.subject | Resistência a medicamentos | |
dc.subject | Terapia com Lamivudina | |
dc.subject | Brasil | |
dc.subject | Hepatitis B virus genotypes | |
dc.subject | resistance mutations | |
dc.subject | lamivudine therapy | |
dc.subject | Brazil | |
dc.title | Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy: characterization of genotype G in Brazil | |
dc.type | Article | |